TY - JOUR
T1 - Suppression of RNA recognition by Toll-like receptors
T2 - The impact of nucleoside modification and the evolutionary origin of RNA
AU - Karikó, Katalin
AU - Buckstein, Michael
AU - Ni, Houping
AU - Weissman, Drew
N1 - Funding Information:
This work was supported by National Institutes of Health grants AI060505, AI50484, and DE14825.
PY - 2005/8
Y1 - 2005/8
N2 - DNA and RNA stimulate the mammalian innate immune system through activation of Toll-like receptors (TLRs). DNA containing methylated CpG motifs, however, is not stimulatory. Selected nucleosides in naturally occurring RNA are also methylated or otherwise modified, but the immunomodulatory effects of these alterations remain untested. We show that RNA signals through human TLR3, TLR7, and TLR8, but incorporation of modified nucleosides m5C, m6A, m5U, s2U, or pseudouridine ablates activity. Dendritic cells (DCs) exposed to such modified RNA express significantly less cytokines and activation markers than those treated with unmodified RNA. DCs and TLR-expressing cells are potently activated by bacterial and mitochondrial RNA, but not by mammalian total RNA, which is abundant in modified nucleosides. We conclude that nucleoside modifications suppress the potential of RNA to activate DCs. The innate immune system may therefore detect RNA lacking nucleoside modification as a means of selectively responding to bacteria or necrotic tissue.
AB - DNA and RNA stimulate the mammalian innate immune system through activation of Toll-like receptors (TLRs). DNA containing methylated CpG motifs, however, is not stimulatory. Selected nucleosides in naturally occurring RNA are also methylated or otherwise modified, but the immunomodulatory effects of these alterations remain untested. We show that RNA signals through human TLR3, TLR7, and TLR8, but incorporation of modified nucleosides m5C, m6A, m5U, s2U, or pseudouridine ablates activity. Dendritic cells (DCs) exposed to such modified RNA express significantly less cytokines and activation markers than those treated with unmodified RNA. DCs and TLR-expressing cells are potently activated by bacterial and mitochondrial RNA, but not by mammalian total RNA, which is abundant in modified nucleosides. We conclude that nucleoside modifications suppress the potential of RNA to activate DCs. The innate immune system may therefore detect RNA lacking nucleoside modification as a means of selectively responding to bacteria or necrotic tissue.
UR - http://www.scopus.com/inward/record.url?scp=23844464444&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2005.06.008
DO - 10.1016/j.immuni.2005.06.008
M3 - Article
C2 - 16111635
AN - SCOPUS:23844464444
SN - 1074-7613
VL - 23
SP - 165
EP - 175
JO - Immunity
JF - Immunity
IS - 2
ER -